SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006302
Filing Date
2020-05-11
Accepted
2020-05-11 17:06:05
Documents
51
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20200331x10q.htm 10-Q 1667743
2 EX-31.1 axsm-20200331ex311b0c912.htm EX-31.1 12061
3 EX-31.2 axsm-20200331ex3126a28f2.htm EX-31.2 11283
4 EX-32.1 axsm-20200331ex32118e45d.htm EX-32.1 5877
5 EX-32.2 axsm-20200331ex322ab0dc7.htm EX-32.2 5856
  Complete submission text file 0001558370-20-006302.txt   4793990

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20200331.xml EX-101.INS 779072
7 EX-101.SCH axsm-20200331.xsd EX-101.SCH 35937
8 EX-101.CAL axsm-20200331_cal.xml EX-101.CAL 28527
9 EX-101.DEF axsm-20200331_def.xml EX-101.DEF 94168
10 EX-101.LAB axsm-20200331_lab.xml EX-101.LAB 356502
11 EX-101.PRE axsm-20200331_pre.xml EX-101.PRE 235058
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 20865912
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences